NewsRoom

Interview with Peter Pang: Where Biosimilar CMC Risk Really Sits Today

(English) Interview with Peter Pang: Where Biosimilar CMC Risk Really Sits Today

对不起,此内容只适用于English。 For the sake of viewer convenience, […]

Frederic

(English) Interview: Biosimilars, a market reaching an inflection point — a conversation with Frederic Bouvier

对不起,此内容只适用于English。 For the sake of viewer convenience, […]

鼎康生物宣布与北京力邦生物在全球贝林妥欧单抗生物类似药项目上达成战略合作

categoryidArraymk-test